Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00035024.xml
Thromb Haemost 2004; 92(04): 883-885
DOI: 10.1055/s-0037-1614195
DOI: 10.1055/s-0037-1614195
Case Report
Use of abciximab in massive pulmonary embolism with free-floating, intra-cardiac thrombi
Further Information
Publication History
Received
11 March 2004
Accepted after revision
26 July 2004
Publication Date:
15 December 2017 (online)
-
References
- 1 Chapoutot L, Nazeyrollas DMetz. et al. Floating right heart thrombi and pulmonary embolism. Cardiology 1996; 87: 169-74.
- 2 Gray HH, Morgan JM, Paneth M. et al. Pulmonary embolectomy for acute massive pulmonary embolism. An analysis of 71 cases. Br Heart J 1988; 60: 196-200.
- 3 Goldhabar SZ. Optimal strategy for diagnosis and treatment of pulmonary embolism due to right atrial thrombus. Mayo Clin Proc 1988; 63: 1261-4.
- 4 Fournier. Thrombus des cavites droites. Arch Mal Coeur 1992; 85: 877-82.
- 5 Cuccia C, Campana M, Franzoni P. et al. Effectiveness of IV rt-PA in the treatment of massive PE. Am Heart J 1993; 126: 468-72.
- 6 Leclercq. Thrombosis flottant de. Arch Mal Coeur 1994; 87: 805-11.
- 7 Goldhaber SZ, Nagel JS, Theard M. et al. Treatment of right atrial thrombus with urokinase. Am Heart J 1988; 115: 884-97.
- 8 Kostantinides S, Geibel A, Olschewski M. et al. Association between thrombolytic treatment and the prognosis of hemodynamically stable patients with major PE. Circulation 1997; 96: 882-8.
- 9 Levine MN. Thrombolytic therapy in PE. Can J Card 1993; 92: 158-59.
- 10 Goldhaber SZ. Thrombolysis for PE. Prog Card Dis 1991; 34: 113-34.
- 11 Jardin F, Dubourg O, Gueret P. et al. Quantitative 2-D echo in massive PE. J Am Coll Card 1987; 10: 1201-6.
- 12 European working group on echocardiography. The European cooperative study on the clinical significance of right heart thrombi. Eur Heart J 1989; 10: 1046-59.
- 13 Farfel Z, Schechter M, Vered Z. et al. Review of echocardiographically diagnosed right heart entrapment of pulmonary emboli-in-transit with emphasis on management. Am Heart J 1987; 113: 171-8.
- 14 Chartier L, Bera J, Delomez M. et al. Freefloating thrombi in the right heart. Circulation 1999; 99: 2779-83.
- 15 Panidis IP, Kotler MN, Mintz GS. et al. Clinical and echocardiographic features of right heart masses. Am Heart J 1984; 745-58.
- 16 Kinney EL, Wright RJ. Efficacy of treatment of patients with echocardiographically detected right heart thrombi. Am Heart J 1989; 118: 569-73.
- 17 Crowell RH, Adams GS, Koilpillai CJ. et al. In vivo right heart thrombus; precursor of life-threatening PE. Chest 1988; 94: 1236-9.
- 18 Greenfield LJ, Kimmel GO, McCurdy 3rd WC. Transverse removal of pulmonary emboli. J Surg Res 1969; 09: 347-52.
- 19 Koning R, Cribier A, Gerber L. et al. A new treatment for severe PE: Percutaneous rheolytic thrombectomy. Circulation 1997; 96: 2498-500.
- 20 Brady AJ, Crake T, Oakley CM. Percutaneous catheter fragmentation and distal dispersion of proximal PE. Lancet 1991; 338: 1186-9.
- 21 Schmitz-Rode T, Janssens U, Duda SH, Massive PE. et al. percutaneous emergency treatment by pigtail rotation catheter. J Am Coll Card 2000; 36: 375-80.
- 22 Tapson VF, Davidson CJ, Kisslo KB. et al. Rapid visualization of massive pulmonary emboli utilizing intravascular ultrasound. Chest 1994; 105 (03) 888-90.
- 23 Tapson VF, Gurbel PA, Witty LA. et al. Pharmacological thrombolysis of experimental PE. Rapid low-dose intraembolic therapy. Chest 1994; 106: 1558-62.
- 24 Murciano JC, Harshaw D, Neschis DG. et al. Platelets inhibit the lysis of pulmonary microemboli. Am J Physiol Lung Cell Mol Physiol 2002; Mar; 282 (03) L529-39.
- 25 Konstantinides S, Schafer K, Thinnes T. et al. Plasminogen activator inhibitor-1 and its cofactor vitronectin stabilize arterial thrombi after vascular injury in mice. Circulation 2001; 103 (04) 576-83.
- 26 Fujii S, Hopkins WE, Sobel BE. Mechanisms contributing to increased synthesis of plasminogen activator inhibitor type 1 in endothelial cells by constituents of platelets and their implications for thrombolysis. Circulation 1991; 83 (02) 645-51.
- 27 Lang IM, Marsh JJ, Olman MA. et al. Expression of type 1 plasminogen activator inhibitor in chronic pulmonary thromboemboli. Circulation 1994; 89 (06) 2715-21.
- 28 Lang IM, Moser KM, Schleef RR. Elevated expression of urokinase-like plasminogen activator and plasminogen activator inhibitor type 1 during the vascular remodeling associated with pulmonary thromboembolism. Arterioscler Thromb Vasc Biol 1998; 18 (05) 808-15.